|1.||Zhou, Ying-Jun: 3 articles (09/2014 - 01/2014)|
|2.||Shao, Xu: 3 articles (01/2013 - 01/2008)|
|3.||Dong, Liuyi: 2 articles (03/2015 - 12/2011)|
|4.||Chen, Zhiwu: 2 articles (03/2015 - 12/2011)|
|5.||Zeng, Guangyao: 2 articles (02/2014 - 03/2012)|
|6.||Yuan, Hong: 2 articles (02/2014 - 01/2014)|
|7.||Deng, Jun: 2 articles (05/2013 - 03/2012)|
|8.||Zhang, Yi: 2 articles (05/2013 - 03/2012)|
|9.||Tan, Zhihui: 2 articles (05/2013 - 03/2012)|
|10.||Dong, Liu-Yi: 2 articles (01/2013 - 01/2008)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
01/01/2013 - "This study was conducted to demonstrate myocardial protective effects and possible underlying mechanisms of vitexin on myocardial ischemia/reperfusion (I/R) injury in rats. "
12/01/2011 - "The aim of the present study is to investigate the effects and its possible underlying mechanisms of vitexin on myocardial ischemia/reperfusion (I/R) injury in isolated rat hearts. "
12/01/2011 - "Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis."
01/01/2013 - "Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway."
01/01/2008 - "This study was aimed at investigating the protective effect and mechanism of vitexin preconditioning (VPC) on cultured neonatal rat cardiomyocytes after anoxia and reoxygenation (A/R). "
01/01/2008 - "Mechanisms of vitexin preconditioning effects on cultured neonatal rat cardiomyocytes with anoxia and reoxygenation."
08/01/2008 - "To study the effect and molecular mechanism of two haw leaf extracts, Vitexin-rhamnoside (VR) and Vitexin-glucoside (VG), and their preparation, Aoshaen injection (AI), on the polymorphonuclear leucocyte (PMN) adhesion during human umbilical vein endothelial cell (HUVEC) anoxia/reoxygenation (A/R) injury. "
09/01/2014 - "Protective effect of vitexin compound B-1 against hypoxia/reoxygenation-induced injury in differentiated PC12 cells via NADPH oxidase inhibition."
01/01/2008 - "These results suggest that vitexin preconditioning has a protective effect on cardiomyocytes A/R injury through the improvement of cell viability, decrease of LDH and CK release, such that the protective mechanism may relate to its ability to inhibit the cardiomyocytes apoptosis, reduce the cardiomyocytes calcium overload and increase the abundance of phosphor-ERK1/2 of the cardiomyocytes after anoxia and reoxygenation."
|3.||Hepatocellular Carcinoma (Hepatoma)
02/01/2014 - "The aim of the current study was to examine whether the Akt/forkhead box protein O3a (FOXO3a) pathway mediates the biological effects of purified vitexin compound 1 (VB-1) in hepatocellular carcinoma (HCC) cells. "
02/01/2014 - "Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma."
01/01/2014 - "Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma."
01/01/2007 - "Antioxidative as well as cytotoxic effects of the prenylated flavonoids licoflavone C (8-prenylapigenin) and isobavachin (8-prenylliquiritigenin) were investigated in comparison to the corresponding non-prenylated flavonoids (apigenin, liquiritigenin) and vitexin (apigenin-C8-glucoside) using metabolically active H4IIE hepatoma and metabolically poorly active C6 glioma cells. "
03/01/2012 - "This study was aimed to determine the antitumor effect of purified vitexin compound 1 (VB1) on choriocarcinoma in vitro and in vivo. "
03/01/2012 - "Vitexin compound 1 could inhibit choriocarcinoma via inducing cell apoptosis and suppressing the mTOR pathway."
03/01/2012 - "Purified vitexin compound 1 suppresses tumor growth and induces cell apoptosis in a mouse model of human choriocarcinoma."
03/01/2012 - "Vitexin compound 1 significantly inhibited the growth of choriocarcinoma in severe combined immunodeficient mice and reduced the serum β-human chorionic gonadotropin level. "
05/01/2013 - "To investigate the effect of purified vitexin compound 2 (VB2), a noval lignanoid from the acetoacetate extract of Vitex negundo seed on the proliferation and apoptosis as well as the expression of mTOR and 4E-BP1 mRNA signal pathway in human choriocarcinoma JEG-3 cell lines in vitro. "
|5.||Neoplasm Metastasis (Metastasis)
|8.||Protein Kinases (Protein Kinase)
|9.||Catechin (Z 7300)
|1.||Heterologous Transplantation (Xenotransplantation)